General practitioners' concepts on issuing out-of-pocket prescriptions for hypnotics and sedatives in Germany.


Journal

Family practice
ISSN: 1460-2229
Titre abrégé: Fam Pract
Pays: England
ID NLM: 8500875

Informations de publication

Date de publication:
18 11 2019
Historique:
pubmed: 9 5 2019
medline: 9 6 2020
entrez: 9 5 2019
Statut: ppublish

Résumé

In Germany, almost 50% of prescriptions for benzodiazepines and drugs as Zolpidem and Zopiclone are as out-of-pocket (OOP) prescriptions-requiring patients to buy the drug at their own expense-although almost 90% of the population has statutory health insurance covering medication costs. To understand why general practitioners (GPs) choose this prescribing method since needed medications are insurance covered, and unnecessary drugs should not be prescribed at all. In this qualitative study, 17 semi-structured interviews with GPs were conducted, audio recorded and transcribed verbatim. Transcripts were analysed with grounded theory to extract a model explaining the described behaviour. Knowing the significant medical risks and insecurity about regulations makes GPs wish to avoid hypnotics and sedatives. They achieve this by 'Creating a barrier' (central phenomenon) and employing the strategy 'Using an out-of-pocket prescription', which not only generates costs for the patient but also reduces the physicians´ legal and financial accountability. The perceived patient type, expected problem duration and diagnosis influence the decision about the prescription form: patients with an alcohol or drug addiction or those with 'uncomplicated' insomnia are more likely to receive an OOP prescription. Patients with any psychiatric diagnosis will likely receive a statutory health insurance prescription. Current regulations do not provide guidance to GPs regarding hypnotics and sedatives. A clear regulatory framework and guidelines could possibly reduce physicians' defensive attitudes about these drugs and their use of OOP prescriptions. The approach to use OOP prescriptions as a barrier to reduce patients' medication use lacks evidence regarding effectiveness.

Sections du résumé

BACKGROUND
In Germany, almost 50% of prescriptions for benzodiazepines and drugs as Zolpidem and Zopiclone are as out-of-pocket (OOP) prescriptions-requiring patients to buy the drug at their own expense-although almost 90% of the population has statutory health insurance covering medication costs.
OBJECTIVE
To understand why general practitioners (GPs) choose this prescribing method since needed medications are insurance covered, and unnecessary drugs should not be prescribed at all.
METHODS
In this qualitative study, 17 semi-structured interviews with GPs were conducted, audio recorded and transcribed verbatim. Transcripts were analysed with grounded theory to extract a model explaining the described behaviour.
RESULTS
Knowing the significant medical risks and insecurity about regulations makes GPs wish to avoid hypnotics and sedatives. They achieve this by 'Creating a barrier' (central phenomenon) and employing the strategy 'Using an out-of-pocket prescription', which not only generates costs for the patient but also reduces the physicians´ legal and financial accountability. The perceived patient type, expected problem duration and diagnosis influence the decision about the prescription form: patients with an alcohol or drug addiction or those with 'uncomplicated' insomnia are more likely to receive an OOP prescription. Patients with any psychiatric diagnosis will likely receive a statutory health insurance prescription.
DISCUSSION
Current regulations do not provide guidance to GPs regarding hypnotics and sedatives. A clear regulatory framework and guidelines could possibly reduce physicians' defensive attitudes about these drugs and their use of OOP prescriptions. The approach to use OOP prescriptions as a barrier to reduce patients' medication use lacks evidence regarding effectiveness.

Identifiants

pubmed: 31066894
pii: 5487061
doi: 10.1093/fampra/cmz018
pmc: PMC6859510
doi:

Substances chimiques

Hypnotics and Sedatives 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

785-790

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press.

Références

Pharmacoepidemiol Drug Saf. 2010 Oct;19(10):1071-7
pubmed: 20665597
Pain Med. 2010 Oct;11(10):1537-45
pubmed: 20807346
J Am Geriatr Soc. 2015 Nov;63(11):2227-46
pubmed: 26446832
J Family Med Prim Care. 2016 Jul-Sep;5(3):652-657
pubmed: 28217600
Addiction. 1998 Aug;93(8):1133-5
pubmed: 9813894
J Gen Intern Med. 2007 Mar;22(3):303-7
pubmed: 17356959
J Am Geriatr Soc. 2012 Apr;60(4):616-31
pubmed: 22376048
Swiss Med Wkly. 2013 Jan 17;143:w13745
pubmed: 23348819
Scand J Prim Health Care. 2007 Dec;25(4):214-9
pubmed: 18041658
JAMA. 1997 Dec 24-31;278(24):2170-7
pubmed: 9417012
Res Social Adm Pharm. 2014 Mar-Apr;10(2):438-47
pubmed: 23880428
Am J Prev Med. 2013 May;44(5):472-6
pubmed: 23597810
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Int Clin Psychopharmacol. 2001 Jul;16(4):227-33
pubmed: 11459337
Ann Fam Med. 2012 Jan-Feb;10(1):42-9
pubmed: 22230829
Addiction. 2011 Dec;106(12):2086-109
pubmed: 21714826
J Aging Stud. 2012 Dec;26(4):484-94
pubmed: 22939545
Fam Pract. 1997 Oct;14(5):361-8
pubmed: 9472369
Pharmacopsychiatry. 1986 Jan;19(1):8-13
pubmed: 2870514
J Am Geriatr Soc. 2013 Apr;61(4):622-31
pubmed: 23469880
Offentl Gesundheitswes. 1984 Feb;46(2):80-6
pubmed: 6142442
Ann Intern Med. 2007 Jan 16;146(2):96-103
pubmed: 17227933
Dtsch Med Wochenschr. 2014 May;139(22):1153-8
pubmed: 24845524

Auteurs

Katharina Schmalstieg-Bahr (K)

Department of General Practice, University Medical Center Göttingen, Göttingen, Germany.

Christiane A Müller (CA)

Department of General Practice, University Medical Center Göttingen, Göttingen, Germany.

Eva Hummers (E)

Department of General Practice, University Medical Center Göttingen, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH